Vascular Response to Implantation of Drug-eluting Stent in femoropopliteal Artery Lesions

Vascular Response to Implantation of Drug-eluting Stent in femoropopliteal Artery Lesions - Vascular Response to Implantation of Drug-eluting Stent in femoropopliteal Artery Lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036499

Enrollment

Registered

2019-07-01

Start date

2019-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Interventions

Anti-platelet therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: De novo femoropopliteal artery lesions

Exclusion criteria

Exclusion criteria: Patients who require long-term DAPT Patients who require anti-coagulant therapy In-stent restenosis

Design outcomes

Primary

Measure	Time frame
Existence of thrombus 6 months after implantation of drug-eluting stent in femoropopliteal artery lesions	—

Secondary

Measure	Time frame
Neointimal proliferation at 6 months Stent thrombosis for 1 year Stent patency at 1 year Bleeding events for 1 year	—

Countries

Japan

Contacts

Public ContactKojiro Miki

Hyogo College of Medicine Division of Cardiovascular Medicine

hpxkg043@ybb.ne.jp0798-45-6553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026